CN116199732A - Method for increasing leaching of effective components of astragalus membranaceus by utilizing sugar - Google Patents
Method for increasing leaching of effective components of astragalus membranaceus by utilizing sugar Download PDFInfo
- Publication number
- CN116199732A CN116199732A CN202110886217.7A CN202110886217A CN116199732A CN 116199732 A CN116199732 A CN 116199732A CN 202110886217 A CN202110886217 A CN 202110886217A CN 116199732 A CN116199732 A CN 116199732A
- Authority
- CN
- China
- Prior art keywords
- sugar
- astragalus
- solution
- sugar alcohol
- sucrose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/40—Separation, e.g. from natural material; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Botany (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
Abstract
Description
技术领域technical field
本发明涉及中药提取领域,具体涉及一种利用糖增加黄芪有效成分浸出的方法。The invention relates to the field of extraction of traditional Chinese medicines, in particular to a method for increasing the leaching of effective components of Astragalus membranaceus by using sugar.
背景技术Background technique
目前,如何高效提取中药有效成分且保证提取物的安全性是中药提取研究领域中的一项重要内容。中药的传统服用方法大多采用水煎煮的方式,临床经验和现代研究表明该方法比有机溶剂提取法更能保证提取物的有效性和安全性。因此,在2020年新发布的中药新药注册及申报中规定,如果所申报的适应症和传统用法一致,则临床试验可以适度减少或者减免,如2018年发布了《古代经典名方中药复方制剂简化注册审批管理规定》明确了古代经典名方复方制剂的开发中可以免临床实验的适用范围,包括制备工艺和古代医籍记载一致。现代研究发现,中药大多成分的乙醇提取效率远高于水煎煮的提取效率,但是所得提取物的毒性增加。导致两种提取方法差异性的主要原因是:中药所含有效成分种类繁多、极性范围宽,乙醇提取增加了弱极性和中等极性成分的提取率,从而导致醇提物与传统临床使用的汤剂中有效成分组成不同,因此对提取物的安全性可能产生一定影响。另外,中药传统提取最常用水煎煮法存在提取率低、提取不完全等问题。At present, how to efficiently extract the active ingredients of traditional Chinese medicine and ensure the safety of the extract is an important content in the research field of traditional Chinese medicine extraction. Most of the traditional methods of taking traditional Chinese medicine are decocted in water. Clinical experience and modern research have shown that this method can guarantee the effectiveness and safety of the extract better than organic solvent extraction. Therefore, in the new registration and application of new traditional Chinese medicines released in 2020, it is stipulated that if the declared indications are consistent with the traditional usage, the clinical trials can be moderately reduced or exempted. The Regulations on the Administration of Registration and Approval clarifies the scope of application where clinical trials can be exempted from the development of ancient classic famous prescription compound preparations, including the preparation process is consistent with the records in ancient medical books. Modern research has found that the ethanol extraction efficiency of most components of traditional Chinese medicine is much higher than that of water decoction, but the toxicity of the obtained extract increases. The main reasons for the difference between the two extraction methods are: Chinese medicine contains a wide variety of active ingredients and a wide range of polarity, and ethanol extraction increases the extraction rate of weakly polar and medium polar components, resulting in ethanol extracts that are different from those used in traditional clinical practice. The composition of active ingredients in the decoction is different, so it may have a certain impact on the safety of the extract. In addition, the most commonly used decoction method for traditional Chinese medicine extraction has problems such as low extraction rate and incomplete extraction.
因此,如何在遵古的基础上,提高中药提取物的提取率是中药提取研究中一个重要的研究方向。Therefore, how to improve the extraction rate of Chinese medicine extracts on the basis of following the ancient times is an important research direction in the study of Chinese medicine extraction.
发明内容Contents of the invention
基于此,本发明提供了一种高效的黄芪饮片提取方法,采用一定浓度的糖水和/或糖醇水代替水为提取溶剂,相比于采用传统的煎煮方法提取,提取率得到显著性提高,从而提高了黄芪药材的利用率和疗效。该研究所用糖是中药常用辅料或者食用糖,因此具有安全、低价等特点,不会对提取物的安全性产生影响。Based on this, the present invention provides a high-efficiency extraction method of Astragalus decoction pieces, using a certain concentration of sugar water and/or sugar alcohol water instead of water as the extraction solvent, compared with the extraction by traditional decoction method, the extraction rate is significantly improved , thereby improving the utilization rate and curative effect of Astragalus medicinal materials. The sugar used in this study is a common excipient or edible sugar in traditional Chinese medicine, so it is safe and low-priced, and will not affect the safety of the extract.
具体而言,根据本发明的一个方面,提供了一种利用糖增加黄芪有效成分浸出的方法,该方法包括以下步骤:Specifically, according to one aspect of the present invention, there is provided a method for utilizing sugar to increase the leaching of active ingredients of Radix Astragalus, the method comprising the following steps:
(1)配制糖溶液和/或糖醇溶液;(1) preparing sugar solution and/or sugar alcohol solution;
(2)将黄芪浸泡于该糖溶液和/或该糖醇溶液中;以及(2) Soaking Radix Astragali in the sugar solution and/or the sugar alcohol solution; and
(3)在该糖溶液和/或该糖醇溶液中加热提取该黄芪,经过滤得到黄芪提取液。(3) Heat and extract the Radix Astragali in the sugar solution and/or the sugar alcohol solution, and obtain an extract of Radix Astragali through filtration.
根据本发明的另一方面,提供了一种利用糖增加黄芪有效成分浸出的方法,其特征在于,该方法包括以下步骤:According to another aspect of the present invention, there is provided a method for utilizing sugar to increase the leaching of active ingredients of Radix Astragali, characterized in that the method comprises the following steps:
(1)配制糖溶液和/或糖醇溶液;(1) preparing sugar solution and/or sugar alcohol solution;
(2)将黄芪浸泡于该糖溶液和/或该糖醇溶液中;(2) Soaking Radix Astragali in the sugar solution and/or the sugar alcohol solution;
(3)在该糖溶液和/或该糖醇溶液中加热提取该黄芪,经过滤得到第一黄芪提取液;(3) heating and extracting the Astragalus membranaceus in the sugar solution and/or the sugar alcohol solution, and obtaining the first Astragalus membranaceus extract by filtering;
(4)在该黄芪中加入该糖溶液和/或该糖醇溶液,加热提取该黄芪,得到第二黄芪提取液;以及(4) adding the sugar solution and/or the sugar alcohol solution to the Radix Astragali, heating and extracting the Radix Astragali to obtain a second extract of Radix Astragali; and
(5)将该第一黄芪提取液和该第二黄芪提取液合并,得到黄芪提取液(即黄芪总提取液或第三黄芪提取液)。(5) Combine the first Astragalus extract and the second Astragalus extract to obtain the Astragalus extract (ie, the total Astragalus extract or the third Astragalus extract).
进一步地,该糖选自单糖、二糖和三糖中的一种或多种。Further, the sugar is selected from one or more of monosaccharides, disaccharides and trisaccharides.
进一步地,该糖醇选自山梨糖醇、甘露糖醇、赤藓糖醇、麦芽糖醇、乳糖醇和木糖醇中一种或多种。Further, the sugar alcohol is selected from one or more of sorbitol, mannitol, erythritol, maltitol, lactitol and xylitol.
进一步地,该单糖选自葡萄糖、果糖、半乳糖、甘露糖、半乳糖、山梨糖、鼠李糖、核糖、木糖和脱氧核糖中的一种或多种。Further, the monosaccharide is selected from one or more of glucose, fructose, galactose, mannose, galactose, sorbose, rhamnose, ribose, xylose and deoxyribose.
进一步地,该二糖选自麦芽糖、蔗糖、乳糖和海藻糖中的一种或多种。Further, the disaccharide is selected from one or more of maltose, sucrose, lactose and trehalose.
进一步地,该单糖为葡萄糖和/或果糖。Further, the monosaccharide is glucose and/or fructose.
进一步地,该二糖选自麦芽糖、蔗糖和海藻糖中的一种或多种。Further, the disaccharide is selected from one or more of maltose, sucrose and trehalose.
进一步地,该三糖为棉籽糖。Further, the trisaccharide is raffinose.
进一步地,该二糖为蔗糖。Further, the disaccharide is sucrose.
进一步地,在该糖溶液或该糖醇溶液中,该糖或该糖醇的浓度范围为0.1-30g/100mL。Further, in the sugar solution or the sugar alcohol solution, the concentration range of the sugar or the sugar alcohol is 0.1-30g/100mL.
进一步地,该糖或该糖醇的浓度范围为0.25-10g/100mL。Further, the concentration range of the sugar or the sugar alcohol is 0.25-10g/100mL.
进一步地,该糖或该糖醇的浓度范围为1-10g/100mL。Further, the concentration range of the sugar or the sugar alcohol is 1-10g/100mL.
进一步地,该糖或该糖醇的浓度范围为1-1.25g/100mL或者该糖或该糖醇的浓度为约10g/100mL。Further, the concentration range of the sugar or the sugar alcohol is 1-1.25g/100mL or the concentration of the sugar or the sugar alcohol is about 10g/100mL.
进一步地,该有效成分包含皂苷类和/或黄酮类化合物。Further, the active ingredient contains saponins and/or flavonoids.
进一步地,该皂苷类化合物为三萜皂苷类化合物。Further, the saponins are triterpene saponins.
进一步地,该皂苷类化合物为黄芪甲苷。Further, the saponin compound is astragaloside IV.
进一步地,该黄酮类化合物为异黄酮类化合物。Further, the flavonoids are isoflavones.
进一步地,该黄酮类化合物选自毛蕊异黄酮葡萄糖苷、芒柄花苷和毛蕊异黄酮中的一种或多种。Further, the flavonoid compound is selected from one or more of acteosin glucoside, formononetin and acteosin.
进一步地,在步骤(2)中,该浸泡为室温浸泡。Further, in step (2), the soaking is soaking at room temperature.
进一步地,该浸泡的步骤包括将该黄芪在室温下浸泡于该糖溶液和/或该糖醇溶液中10-120min。Further, the step of soaking includes soaking the astragalus root in the sugar solution and/or the sugar alcohol solution for 10-120 minutes at room temperature.
进一步地,该浸泡的步骤包括将该黄芪在室温下浸泡于该糖溶液和/或该糖醇溶液中20-60min。Further, the step of soaking includes soaking the astragalus root in the sugar solution and/or the sugar alcohol solution for 20-60 minutes at room temperature.
进一步地,该浸泡的步骤包括将该黄芪在室温下浸泡于该糖溶液和/或该糖醇溶液中约30min。Further, the step of soaking includes soaking the astragalus in the sugar solution and/or the sugar alcohol solution at room temperature for about 30 minutes.
进一步地,该黄芪与该糖溶液和/或该糖醇溶液的重量体积比为 1:1~1:50。Further, the weight-to-volume ratio of the astragalus to the sugar solution and/or the sugar alcohol solution is 1:1-1:50.
进一步地,该黄芪与该糖溶液和/或该糖醇溶液的重量体积比为 1:1~1:20。Further, the weight-to-volume ratio of the astragalus to the sugar solution and/or the sugar alcohol solution is 1:1-1:20.
进一步地,该黄芪与该糖溶液和/或该糖醇溶液的重量体积比为 1:6~1:7。Further, the weight-to-volume ratio of the astragalus to the sugar solution and/or the sugar alcohol solution is 1:6-1:7.
进一步地,在步骤(3)中,该加热提取为加热回流提取。Further, in step (3), the heating extraction is heating reflux extraction.
进一步地,该加热的时间为20min至60min。Further, the heating time is 20 minutes to 60 minutes.
进一步地,该加热的时间为约30min。Further, the heating time is about 30 minutes.
根据本发明的另一方面,提供了一种根据上述方法在制备黄芪提取液或黄芪浓缩液中的用途。According to another aspect of the present invention, there is provided a use of the above method in the preparation of astragalus extract or astragalus concentrate.
进一步地,该黄芪浓缩液为步骤(5)中获得的黄芪提取液(即黄芪总提取液或第三黄芪提取液)在20℃至100℃水浴下浓缩获得的。Further, the Astragalus concentrated solution is obtained by concentrating the Astragalus extract obtained in step (5) (ie, the total Astragalus extract or the third Astragalus extract) in a water bath at 20°C to 100°C.
进一步地,在步骤(5)中,该浓缩在60℃至80℃水浴下完成。Further, in step (5), the concentration is completed in a water bath at 60°C to 80°C.
进一步地,该浓缩在约70℃水浴下完成。Further, the concentration is completed in a water bath at about 70°C.
根据本发明的另一方面,提供了一种根据上述方法在制备含有黄芪的药物组合物中的用途。According to another aspect of the present invention, there is provided a use of the above method in the preparation of a pharmaceutical composition containing astragalus.
根据本发明的另一方面,提供了一种根据上述方法在制备含有黄芪的药物制剂、功能食品、保健食品及其它产品中的用途。According to another aspect of the present invention, there is provided a use of the above method in the preparation of pharmaceutical preparations, functional foods, health foods and other products containing astragalus.
本发明的有益效果:Beneficial effects of the present invention:
黄芪为常用中药材,其为豆科植物蒙古黄芪的根。春、秋季采挖,除去泥土、须根及根头,晒至六七成干,理直扎捆后晒干。功能主治为:补气固表,托毒排脓,利尿,生肌。黄芪的主要化学成分有黄芪多糖、皂苷类、黄酮类和氨基酸等;其药理作用为提高免疫功能,增强抗氧化、抗辐射和抗癌作用,保护心脑血管、肝脏、肾脏和肺脏作用,保护脑细胞、提高记忆力,舒张血管平滑肌,激素样作用,抗菌及抑制病毒作用,降血脂、降血糖、减少糖尿病并发症等。我们研究发现,与传统水煎煮方式相比,本发明的方法能充分提高黄芪有效成分的提取率。Astragalus is a commonly used Chinese medicinal material, which is the root of the leguminous plant Astragalus mongolica. Excavated in spring and autumn, removed the soil, fibrous roots and root heads, sun-dried to 60-70% dry, straightened and bundled, then dried in the sun. Functions and indications are: invigorating qi and solidifying the surface, detoxification and pus drainage, diuresis, and muscle regeneration. The main chemical components of Astragalus are astragalus polysaccharides, saponins, flavonoids and amino acids; its pharmacological effects are to improve immune function, enhance anti-oxidation, anti-radiation and anti-cancer effects, protect cardiovascular and cerebrovascular, liver, kidney and lung functions, protect Brain cells, improve memory, dilate vascular smooth muscle, hormone-like effects, antibacterial and virus-inhibiting effects, lower blood lipids, lower blood sugar, reduce complications of diabetes, etc. Our research has found that, compared with the traditional water decocting method, the method of the present invention can fully improve the extraction rate of the effective components of Astragalus membranaceus.
具体实施方式Detailed ways
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present invention in conjunction with the embodiments of the present invention. Apparently, the described embodiments are part of the embodiments of the present invention, but not all of them. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without making creative efforts belong to the protection scope of the present invention.
需要说明的是,在不冲突的情况下,本发明中的实施例及实施例中的特征可以相互组合。下面将结合实施例来详细说明本发明。It should be noted that, in the case of no conflict, the embodiments of the present invention and the features in the embodiments can be combined with each other. The present invention will be described in detail below in conjunction with examples.
以下结合具体实施例对本发明作进一步详细描述,这些实施例不能理解为限制本发明所要求保护的范围。The present invention will be described in further detail below in conjunction with specific examples, and these examples should not be construed as limiting the scope of protection claimed by the present invention.
正如背景技术部分所描述的,醇提物与传统临床使用的汤剂中有效成分组成不同,因此对醇提取物的安全性可能产生一定影响,但是传统水煎煮的提取效率又不高。为了解决上述问题,本发明提供了一种利用糖增加黄芪有效成分浸出的方法,该方法包括以下步骤:As described in the background technology section, the alcohol extract is different from the active ingredients in the traditional clinical decoction, so it may have a certain impact on the safety of the alcohol extract, but the extraction efficiency of traditional water decoction is not high. In order to solve the above problems, the present invention provides a method for utilizing sugar to increase the leaching of active ingredients of Radix Astragalus, the method comprising the following steps:
(1)配制糖溶液和/或糖醇溶液;(1) preparing sugar solution and/or sugar alcohol solution;
(2)将黄芪浸泡于该糖溶液和/或该糖醇溶液中;以及(2) Soaking Radix Astragali in the sugar solution and/or the sugar alcohol solution; and
(3)在该糖溶液和/或该糖醇溶液中加热提取该黄芪,经过滤得到黄芪提取液。(3) Heat and extract the Radix Astragali in the sugar solution and/or the sugar alcohol solution, and obtain an extract of Radix Astragali through filtration.
糖溶液和/或糖醇溶液能够提高黄芪中有效成分的提取率主要与两个方面的因素有关:The ability of sugar solution and/or sugar alcohol solution to improve the extraction rate of active ingredients in Radix Astragali is mainly related to two factors:
(1)液体能否浸润固体饮片,与其表面张力有关。表面张力系数小者(30×10-3N/m左右),几乎能浸润固体;水的表面张力系数较大,它只能浸润某些固体。糖水溶液的表面张力系数比纯水的表面张力系数小,溶液能更好进入植物细胞内,释放有效成分,因此能提高黄芪饮片的浸润,提高有效成分溶出;(1) Whether the liquid can infiltrate the solid decoction pieces is related to its surface tension. Those with a small surface tension coefficient (about 30×10 -3 N/m) can almost wet solids; water has a large surface tension coefficient, and it can only wet certain solids. The surface tension coefficient of sugar aqueous solution is smaller than that of pure water, so the solution can better enter the plant cells and release active ingredients, so it can improve the infiltration of Astragalus decoction pieces and the dissolution of active ingredients;
(2)糖能和黄芪饮片中活性成分之间形成氢键等作用力,因此提升了黄芪提取物成分的提取效率;(2) The sugar can form hydrogen bonds and other forces between the active ingredients in the Astragalus decoction pieces, thus improving the extraction efficiency of the Astragalus extract components;
因此,与水煎煮方式相比,该方法能充分提高黄芪有效成分的提取率。Therefore, compared with water decoction, this method can fully improve the extraction rate of effective components of Astragalus membranaceus.
在实际工作过程中,可根据实际需要确定醇和/或糖醇溶液的提取次数,可以是1次,也可以是数次,例如2-10次。In the actual working process, the number of extractions of the alcohol and/or sugar alcohol solution can be determined according to actual needs, which can be one time or several times, such as 2-10 times.
根据本发明的另一方面,提供了一种利用糖增加黄芪有效成分浸出的方法,其特征在于,该方法包括以下步骤:According to another aspect of the present invention, there is provided a method for utilizing sugar to increase the leaching of active ingredients of Radix Astragali, characterized in that the method comprises the following steps:
(1)配制糖溶液和/或糖醇溶液;(1) preparing sugar solution and/or sugar alcohol solution;
(2)将黄芪浸泡于该糖溶液和/或该糖醇溶液中;(2) Soaking Radix Astragali in the sugar solution and/or the sugar alcohol solution;
(3)在该糖溶液和/或该糖醇溶液中加热提取该黄芪,经过滤得到第一黄芪提取液;(3) heating and extracting the Astragalus membranaceus in the sugar solution and/or the sugar alcohol solution, and obtaining the first Astragalus membranaceus extract by filtering;
(4)在该黄芪中加入该糖溶液和/或该糖醇溶液,加热提取该黄芪,得到第二黄芪提取液;以及(4) adding the sugar solution and/or the sugar alcohol solution to the Radix Astragali, heating and extracting the Radix Astragali to obtain a second extract of Radix Astragali; and
(5)将该第一黄芪提取液和该第二黄芪提取液合并,得到黄芪提取液(即黄芪总提取液或第三黄芪提取液)。(5) Combine the first Astragalus extract and the second Astragalus extract to obtain the Astragalus extract (ie, the total Astragalus extract or the third Astragalus extract).
关于数值的术语“约”或“大约”意指该数值的±5%,但明确地包括确切的数值。例如,“约”0.5g生药/mL的浓度是指从0.475g生药/mL至0.525g生药/mL的浓度,但也明确地包括刚好0.5g生药/mL 的浓度。The term "about" or "approximately" with respect to a numerical value means ± 5% of the numerical value, but expressly includes the exact numerical value. For example, a concentration of "about" 0.5 g crude drug/mL refers to a concentration of from 0.475 g crude drug/mL to 0.525 g crude drug/mL, but specifically includes concentrations of exactly 0.5 g crude drug/mL.
在一种优选的实施方式中,该糖选自单糖、二糖和三糖中的一种或多种。In a preferred embodiment, the sugar is selected from one or more of monosaccharides, disaccharides and trisaccharides.
在一种优选的实施方式中,该糖醇选自山梨糖醇、甘露糖醇、赤藓糖醇、麦芽糖醇、乳糖醇和木糖醇中一种或多种。在实际应用过程中,可根据实际情况从而将上述糖醇替换成现有技术的其它糖醇。In a preferred embodiment, the sugar alcohol is selected from one or more of sorbitol, mannitol, erythritol, maltitol, lactitol and xylitol. During practical application, the above-mentioned sugar alcohols can be replaced with other sugar alcohols in the prior art according to the actual situation.
在一种优选的实施方式中,该单糖选自葡萄糖、果糖、半乳糖、甘露糖、半乳糖、山梨糖、鼠李糖、核糖、木糖和脱氧核糖中的一种或多种。在实际应用过程中,可根据实际情况从而将上述单糖替换成现有技术的其它单糖。In a preferred embodiment, the monosaccharide is selected from one or more of glucose, fructose, galactose, mannose, galactose, sorbose, rhamnose, ribose, xylose and deoxyribose. During practical application, the above-mentioned monosaccharides can be replaced with other monosaccharides in the prior art according to the actual situation.
在一种优选的实施方式中,该二糖选自麦芽糖、蔗糖、乳糖和海藻糖中的一种或多种。在实际应用过程中,可根据实际情况从而将上述二糖替换成现有技术的其它二糖。In a preferred embodiment, the disaccharide is selected from one or more of maltose, sucrose, lactose and trehalose. During practical application, the above-mentioned disaccharides can be replaced with other disaccharides in the prior art according to the actual situation.
在一种优选的实施方式中,该单糖为葡萄糖和/或果糖。In a preferred embodiment, the monosaccharide is glucose and/or fructose.
在一种优选的实施方式中,该二糖选自麦芽糖、蔗糖和海藻糖中的一种或多种。In a preferred embodiment, the disaccharide is selected from one or more of maltose, sucrose and trehalose.
在一种优选的实施方式中,该三糖为棉籽糖。In a preferred embodiment, the trisaccharide is raffinose.
为了进一步提高黄芪中有效成分的提取率,在一种优选的实施方式中,该二糖为蔗糖。In order to further increase the extraction rate of active ingredients in Radix Astragali, in a preferred embodiment, the disaccharide is sucrose.
在一种优选的实施方式中,在该糖溶液或该糖醇溶液中,该糖或该糖醇的浓度范围为0.1-30g/100mL。In a preferred embodiment, in the sugar solution or the sugar alcohol solution, the concentration of the sugar or the sugar alcohol is in the range of 0.1-30g/100mL.
在一种优选的实施方式中,该糖或该糖醇的浓度范围为0.25-10 g/100mL。In a preferred embodiment, the concentration range of the sugar or the sugar alcohol is 0.25-10 g/100mL.
在一种优选的实施方式中,该糖或该糖醇的浓度范围为1-10g/100 mL。In a preferred embodiment, the concentration of the sugar or the sugar alcohol is in the range of 1-10 g/100 mL.
为了进一步提高黄芪中有效成分的提取率,在一种优选的实施方式中,该糖或该糖醇的浓度范围为1-1.25g/100mL或者该糖或该糖醇的浓度为约10g/100mL。In order to further improve the extraction rate of active ingredients in Radix Astragali, in a preferred embodiment, the concentration range of the sugar or the sugar alcohol is 1-1.25g/100mL or the concentration of the sugar or the sugar alcohol is about 10g/100mL .
关于数值的术语“约”或“大约”意指该数值的±5%,但明确地包括确切的数值。例如,“约”10g/100mL的浓度是指从9.5g/100mL 至10.5g/100mL的浓度,但也明确地包括刚好10g/100mL的浓度。The term "about" or "approximately" with respect to a numerical value means ± 5% of the numerical value, but expressly includes the exact numerical value. For example, a concentration of "about" 10 g/100 mL refers to a concentration of from 9.5 g/100 mL to 10.5 g/100 mL, but expressly includes concentrations of exactly 10 g/100 mL.
在一种优选的实施方式中,该有效成分包含皂苷类和/或黄酮类化合物。In a preferred embodiment, the active ingredient contains saponins and/or flavonoids.
在一种优选的实施方式中,该皂苷类化合物为三萜皂苷类化合物。在实际应用过程中,该皂苷类化合物包括除了三萜皂苷类化合物之外的现有技术已经从黄芪中鉴定的其它皂苷类化合物。In a preferred embodiment, the saponins are triterpene saponins. In practical application, the saponins include other saponins that have been identified from Radix Astragali in the prior art except the triterpene saponins.
在一种优选的实施方式中,该皂苷类化合物为黄芪甲苷。In a preferred embodiment, the saponin compound is astragaloside IV.
在一种优选的实施方式中,该黄酮类化合物为异黄酮类化合物。In a preferred embodiment, the flavonoids are isoflavones.
在实际应用过程中,该黄酮类化合物包括除了异黄酮类化合物之外的现有技术已经从黄芪中鉴定的其它黄酮类化合物。In practical application, the flavonoids include other flavonoids that have been identified from Radix Astragalus in the prior art except the isoflavones.
在一种优选的实施方式中,该黄酮类化合物选自毛蕊异黄酮葡萄糖苷、芒柄花苷和毛蕊异黄酮中的一种或多种。In a preferred embodiment, the flavonoid compound is selected from one or more of acteosin glucoside, formononetin and actecoisoflavone.
在一种优选的实施方式中,在步骤(2)中,该浸泡为室温浸泡。In a preferred embodiment, in step (2), the soaking is soaking at room temperature.
在一种优选的实施方式中,该浸泡的步骤包括将该黄芪在室温下浸泡于该糖溶液和/或该糖醇溶液中10-120min。In a preferred embodiment, the soaking step comprises soaking the astragalus root in the sugar solution and/or the sugar alcohol solution for 10-120 minutes at room temperature.
在一种优选的实施方式中,该浸泡的步骤包括将该黄芪在室温下浸泡于该糖溶液和/或该糖醇溶液中20-60min。In a preferred embodiment, the step of soaking comprises soaking the astragalus in the sugar solution and/or the sugar alcohol solution for 20-60 minutes at room temperature.
在一种优选的实施方式中,该浸泡的步骤包括将该黄芪在室温下浸泡于该糖溶液和/或该糖醇溶液中约30min。In a preferred embodiment, the step of soaking includes soaking the astragalus in the sugar solution and/or the sugar alcohol solution at room temperature for about 30 minutes.
关于数值的术语“约”或“大约”意指该数值的±5%,但明确地包括确切的数值。例如,“约”30min的时间是指从28.5min至31.5min 的时间,但也明确地包括刚好30min的时间。The term "about" or "approximately" with respect to a numerical value means ± 5% of the numerical value, but expressly includes the exact numerical value. For example, a time of "about" 30 min refers to a time from 28.5 min to 31.5 min, but also expressly includes a time of exactly 30 min.
在一种优选的实施方式中,该黄芪与该糖溶液和/或该糖醇溶液的重量体积比为1:1~1:50。In a preferred embodiment, the weight-to-volume ratio of the astragalus to the sugar solution and/or the sugar alcohol solution is 1:1˜1:50.
在一种优选的实施方式中,该黄芪与该糖溶液和/或该糖醇溶液的重量体积比为1:1~1:20。In a preferred embodiment, the weight-to-volume ratio of the astragalus to the sugar solution and/or the sugar alcohol solution is 1:1˜1:20.
在一种优选的实施方式中,该黄芪与该糖溶液和/或该糖醇溶液的重量体积比为1:6~1:7。In a preferred embodiment, the weight-to-volume ratio of the astragalus to the sugar solution and/or the sugar alcohol solution is 1:6˜1:7.
在一种优选的实施方式中,在步骤(3)中,该加热提取为加热回流提取。In a preferred embodiment, in step (3), the heating extraction is heating reflux extraction.
在一种优选的实施方式中,该加热的时间为20min至60min。In a preferred embodiment, the heating time is 20 minutes to 60 minutes.
在一种优选的实施方式中,该加热的时间为约30min。In a preferred embodiment, the heating time is about 30 minutes.
关于数值的术语“约”或“大约”意指该数值的±5%,但明确地包括确切的数值。例如,“约”30min的时间是指从28.5min至31.5min 的时间,但也明确地包括刚好30min的时间。The term "about" or "approximately" with respect to a numerical value means ± 5% of the numerical value, but expressly includes the exact numerical value. For example, a time of "about" 30 min refers to a time from 28.5 min to 31.5 min, but also expressly includes a time of exactly 30 min.
根据本发明的另一方面,提供了一种根据上述方法在制备黄芪提取液或黄芪浓缩液中的用途。According to another aspect of the present invention, there is provided a use of the above method in the preparation of astragalus extract or astragalus concentrate.
在一种优选的实施方式中,该黄芪浓缩液为步骤(5)中获得的黄芪提取液(即黄芪总提取液或第三黄芪提取液)在20℃至100℃水浴下浓缩获得的。In a preferred embodiment, the Astragalus concentrated solution is obtained by concentrating the Astragalus extract obtained in step (5) (ie the total Astragalus extract or the third Astragalus extract) in a water bath at 20°C to 100°C.
在一种优选的实施方式中,在步骤(5)中,该浓缩在60℃至80℃水浴下完成。In a preferred embodiment, in step (5), the concentration is completed in a water bath at 60°C to 80°C.
在一种优选的实施方式中,该浓缩在约70℃水浴下完成。In a preferred embodiment, the concentration is accomplished in a water bath at about 70°C.
关于数值的术语“约”或“大约”意指该数值的±5%,但明确地包括确切的数值。例如,“约”70℃的温度是指从66.5℃至73.5℃的比例,但也明确地包括刚好70℃的温度。The term "about" or "approximately" with respect to a numerical value means ± 5% of the numerical value, but expressly includes the exact numerical value. For example, a temperature of "about" 70°C refers to a scale from 66.5°C to 73.5°C, but also expressly includes a temperature of exactly 70°C.
根据本发明的另一方面,提供了一种根据上述方法在制备含有黄芪的药物组合物中的用途。According to another aspect of the present invention, there is provided a use of the above method in the preparation of a pharmaceutical composition containing astragalus.
根据本发明的另一方面,提供了一种根据上述方法在制备含有黄芪的药物制剂、功能食品、保健食品及其它产品中的用途。According to another aspect of the present invention, there is provided a use of the above method in the preparation of pharmaceutical preparations, functional foods, health foods and other products containing astragalus.
其中功能食品是可以令人信服地证明对身体某种或多种机能有益处,有足够营养效果改善健康状况或能减少患病的食品。Among them, functional foods are foods that can be convincingly proven to be beneficial to one or more functions of the body, have sufficient nutritional effects to improve health status, or reduce illness.
其中保健食品是指声称具有特定保健功能或者以补充维生素、矿物质为目的的食品,即适宜于特定人群食用,具有调节机体功能,不以治疗疾病为目的,并且对人体不产生任何急性、亚急性或者慢性危害的食品。Among them, health food refers to food that claims to have specific health functions or to supplement vitamins and minerals, that is, it is suitable for consumption by specific groups of people, has the function of regulating the body, is not for the purpose of treating diseases, and does not cause any acute, sub-standard effects on the human body. Acute or chronic hazard food.
其中其它产品是指含有黄芪的除药物制剂、功能食品和保健食品之外的所有现有技术所包括的产品,包括液态和固态等形式。Wherein other products refer to all products included in the prior art except pharmaceutical preparations, functional foods and health foods containing astragalus, including liquid and solid forms.
实施例一不同糖溶液提取生黄芪饮片实验Example 1 Experiment of Extracting Raw Astragalus Pieces with Different Sugar Solutions
1.1不同糖-黄芪提取液的制备方法(不同1%糖提取两次)1.1 Preparation method of different sugar-Astragalus extract (extract twice with different 1% sugar)
同一批次生黄芪饮片(来源于山西浑源)取5份(HQ,HQ+1%蔗糖,HQ+1%葡萄糖,HQ+1%果糖,HQ+1%海藻糖),每份50g。分别加入7倍量的水(350ml水),1%葡萄糖水溶液(3.5g葡萄糖加水定容于350ml),1%果糖水溶液(3.5g果糖加水定容于350ml),1%蔗糖水溶液(3.5g蔗糖加水定容于350ml),1%海藻糖水溶液(3.5g 海藻糖加水定容于350ml),浸泡30min,回流30min,趁热用纱布过滤,药渣再分别加6倍量水(300ml水),1%葡萄糖水溶液(3.0g葡萄糖加水定容于300ml),1%果糖水溶液(3.0g果糖加水定容于300ml), 1%蔗糖水溶液(3.0g蔗糖加水定容于300ml),1%海藻糖水溶液(3.0g 海藻糖加水定容于300ml),回流20min,趁热过滤,合并2次滤液,得到不同糖-黄芪提取液。The same batch of raw Astragalus decoction pieces (from Hunyuan, Shanxi) took 5 parts (HQ, HQ+1% sucrose, HQ+1% glucose, HQ+1% fructose, HQ+1% trehalose), 50g each. Add 7 times the amount of water (350ml water), 1% aqueous glucose solution (3.5g glucose and water to 350ml), 1% fructose aqueous solution (3.5g fructose and water to 350ml), 1% sucrose aqueous solution (3.5g sucrose Add water to 350ml), 1% trehalose aqueous solution (3.5g trehalose, add water to 350ml), soak for 30min, reflux for 30min, filter with gauze while it is hot, add 6 times the amount of water (300ml water) to the dregs, 1% aqueous glucose solution (3.0g glucose with water to 300ml), 1% fructose aqueous solution (3.0g fructose with water to 300ml), 1% sucrose aqueous solution (3.0g sucrose with water to 300ml), 1% trehalose aqueous solution (Add 3.0 g of trehalose to 300 ml of water), reflux for 20 minutes, filter while hot, and combine the two filtrates to obtain different sugars-extracts of Astragalus membranaceus.
1.2黄芪甲苷,毛蕊异黄酮葡萄糖苷,芒柄花苷和毛蕊异黄酮含量测定1.2 Determination of astragaloside IV, acteosin glucoside, formononetin and acteosin
1.2.1仪器及试药1.2.1 Instruments and reagents
Agilent 1260型高效液相色谱仪,配有DAD检测器(美国安捷伦公司);Agilent1200型高效液相色谱仪,配有ELSD检测器(美国安捷伦公司);DZKW-4型电子恒温水浴锅(北京中兴伟业仪器有限公司);DK-98-IIA电热恒温水浴锅(天津市泰斯特仪器有限公司);ME204/02型电子天平[梅特勒–托利多仪器(上海)有限公司,十万分之一天平];KQ-250DE型数控超声波清洗器(昆山市超声仪器有限公司); HC-3018高速离心机(安徽中科中佳科学仪器有限公司);固相萃取小柱UniEIutC18EC柱(1000mg/6ml)(华谱科仪北京科技有限公司)。Agilent 1260 high performance liquid chromatograph equipped with DAD detector (Agilent Corporation, USA); Agilent 1200 high performance liquid chromatography instrument equipped with ELSD detector (Agilent Corporation USA); DZKW-4 electronic constant temperature water bath (Beijing ZTE Weiye Instrument Co., Ltd.); DK-98-IIA electric heating constant temperature water bath (Tianjin Test Instrument Co., Ltd.); ME204/02 electronic balance [Mettler-Toledo Instrument (Shanghai) Co., Ltd., parts per 100,000 One day level]; KQ-250DE type numerical control ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); HC-3018 high-speed centrifuge (Anhui Zhongke Zhongjia Scientific Instrument Co., Ltd.); solid phase extraction column UniEIutC18EC column (1000mg/6ml ) (China Spectrum Instrument Beijing Technology Co., Ltd.).
对照品黄芪甲苷(批号CHB170727),毛蕊异黄酮葡萄糖苷(批号CHB161105),芒柄花苷(批号CHB150517),毛蕊异黄酮(批号 CHB161104)均购自成都克洛玛生物科技有限公司,纯度为HPlC≥ 98%;乙腈(色谱纯,赛默飞世尔科技有限公司),甲醇(色谱纯,赛默飞世尔科技有限公司),甲酸为分析纯,购于国药集团化学试剂有限公司;水为娃哈哈纯净水。The reference substance astragaloside (batch number CHB170727), calycosin glucoside (batch number CHB161105), formononetin (batch number CHB150517), and acteocoside (batch number CHB161104) were all purchased from Chengdu Croma Biotechnology Co., Ltd., with a purity of HPlC≥ 98%; Acetonitrile (chromatographically pure, Thermo Fisher Scientific Co., Ltd.), methanol (chromatographically pure, Thermo Fisher Scientific Co., Ltd.), formic acid is analytically pure, purchased from Sinopharm Chemical Reagent Co., Ltd.; water is Wahaha pure water.
1.2.2供试品溶液的制备1.2.2 Preparation of the test solution
皂苷类成分供试品溶液的制备:取不同糖-黄芪提取液5ml,加入 20ml60%甲醇,超声混合,加入10ml氨水,混匀,置于3600r/min离心10min,上清液过华谱UniEIut C18 EC柱(1000mg/6ml),用10ml 纯净水洗脱,再用5ml甲醇洗脱,收集甲醇洗脱液,8000r/min离心5min,取上清液,过0.45μm微孔滤膜,即得。The preparation of saponins component need testing solution: get different sugar-astragali extract 5ml, add 20ml60% methyl alcohol, ultrasonically mix, add 10ml ammoniacal liquor, mix well, be placed in 3600r/min centrifugal 10min, supernatant passes Chinese spectrum UniEIut C18 EC column (1000mg/6ml), elute with 10ml of pure water, then 5ml of methanol, collect the methanol eluate, centrifuge at 8000r/min for 5min, take the supernatant, pass through a 0.45μm microporous membrane to obtain the product.
黄酮类成分供试品溶液的制备:取不同糖-黄芪提取液300μl加水 700μl,置1.5ml离心管中,12000r/min离心5min,取上清,过0.45μm 微孔滤膜,即得。Preparation of the test solution of flavonoid components: Take 300 μl of different sugar-astragalus extracts, add 700 μl of water, put them in a 1.5ml centrifuge tube, centrifuge at 12000r/min for 5min, take the supernatant, and pass through a 0.45μm microporous membrane to obtain the product.
1.2.3对照品溶液的制备1.2.3 Preparation of reference solution
取黄芪甲苷,毛蕊异黄酮葡萄糖苷,芒柄花苷和毛蕊异黄酮对照品适量,精密称定,加甲醇制备1mg/ml的储备液。将储备液稀释成不同系列浓度,建立工作曲线。Take astragaloside IV, acteosin glucoside, formononetin and acteosin reference substance appropriate amount, accurately weighed, add methanol to prepare 1mg/ml stock solution. Dilute the stock solution into different serial concentrations to establish a working curve.
黄芪甲苷的线性方程为lnY=1.3271lnX+9.9314,r=1.0000;毛蕊异黄酮葡萄糖苷的线性方程为Y=35129X+14,r=0.9998;芒柄花苷的线性方程为Y=10024X+33,r=0.9998;毛蕊异黄酮的线性方程为 Y=4656X+25,r=0.9995。The linear equation of astragaloside IV is lnY=1.3271lnX+9.9314, r=1.0000; the linear equation of actecoside glucoside is Y=35129X+14, r=0.9998; the linear equation of formononetin is Y=10024X+33, r=0.9998; the linear equation of calycosin is Y=4656X+25, r=0.9995.
1.2.4含量测定方法1.2.4 Content determination method
皂苷类成分含量测定方法:采用Agilent 1200型液相色谱仪(配有 ELSD检测器)进行分析,色谱柱:Thermo Acclaim 120 C18 (250×4.6mm,5μm);流动相:0.1%甲酸水(A)~0.1%甲酸乙腈(B),梯度洗脱:0~5min,5%~10%B;5~10min,10%~32%B;10~30min, 32%~45%B;30~35min,45%~95%B;35~40min,95%~20%B),柱温:室温,流速1ml/min,漂移管温度100℃,载气流速2.5l/min,进样量 20μl。Determination method of saponins content: adopt Agilent 1200 type liquid chromatograph (equipped with ELSD detector) to analyze, chromatographic column: Thermo Acclaim 120 C18 (250 * 4.6mm, 5 μ m); Mobile phase: 0.1% formic acid water (A )~0.1% formic acid acetonitrile (B), gradient elution: 0~5min, 5%~10%B; 5~10min, 10%~32%B; 10~30min, 32%~45%B; 30~35min , 45%~95%B; 35~40min, 95%~20%B), column temperature: room temperature, flow rate 1ml/min, drift tube temperature 100°C, carrier gas flow rate 2.5l/min, injection volume 20μl.
黄酮类成分含量测定方法:采用Agilent 1260型高效液相色谱仪 (配有DAD检测器)进行分析,色谱柱:Thermo Acclaim 120 C18 (250×4.6mm,5μm);流动相:0.1%甲酸水溶液(A)与0.1%甲酸乙腈(B),梯度洗脱:0~8min,5%~20%B;8~15min,20%~25%B;15~20min, 25%B;20~30min,25%~40%B;30~40min,40%~60%B;流速1ml/min;检测波长260nm;柱温25℃;进样量10μl。Flavonoid content determination method: adopt Agilent 1260 type high performance liquid chromatograph (equipped with DAD detector) to analyze, chromatographic column: Thermo Acclaim 120 C18 (250 * 4.6mm, 5 μ m); Mobile phase: 0.1% formic acid aqueous solution ( A) with 0.1% formic acid acetonitrile (B), gradient elution: 0~8min, 5%~20%B; 8~15min, 20%~25%B; 15~20min, 25%B; 20~30min, 25% % ~ 40% B; 30 ~ 40min, 40% ~ 60% B; flow rate 1ml/min; detection wavelength 260nm; column temperature 25 ℃; injection volume 10μl.
1.3实验结果1.3 Experimental results
不同糖-黄芪提取液中有效成分含量测定结果如表1所示。Table 1 shows the content determination results of active ingredients in different sugar-astragalus extracts.
表1不同糖-黄芪提取液中有效成分含量测定结果Table 1 Determination results of active ingredients in different sugar-astragalus extracts
*P<0.05VS水*P<0.05 VS water
从表1中可以看出,蔗糖、葡萄糖、果糖、海藻糖(1g/100ml 浓度)均能够不同程度地提升黄芪中有效成分含量,其中以蔗糖和海藻糖的效果最为明显,但是采用蔗糖比海藻糖更加经济。As can be seen from Table 1, sucrose, glucose, fructose, and trehalose (1g/100ml concentration) can all increase the content of active ingredients in Astragalus membranaceus to varying degrees, and the effects of sucrose and trehalose are the most obvious, but the ratio of sucrose to seaweed Sugar is more economical.
实施例二不同糖溶液提取生黄芪饮片实验Example 2 Experiment of Extracting Raw Astragalus Pieces with Different Sugar Solutions
2.1不同糖-黄芪提取液的制备方法(不同1%糖提取一次)2.1 Preparation method of different sugar-Astragalus extract (extract once with different 1% sugar)
同一批次生黄芪饮片(来源于山西浑源)取4份(HQ,HQ+1%葡萄糖,HQ+1%蔗糖,HQ+1%麦芽糖),每份50g。分别加入7倍量的水(350ml水),1%葡萄糖水溶液(3.5g葡萄糖加水定容于350ml), 1%蔗糖水溶液(3.5g蔗糖加水定容于350ml),1%麦芽糖水溶液(3.5g 麦芽糖加水定容于350ml),浸泡30min,回流30min,趁热用纱布过滤,得到不同糖-黄芪提取液。The same batch of raw Astragalus decoction pieces (from Hunyuan, Shanxi) took 4 parts (HQ, HQ+1% glucose, HQ+1% sucrose, HQ+1% maltose), each 50g. Add 7 times the amount of water (350ml water), 1% glucose aqueous solution (3.5g glucose is added to 350ml with water), 1% sucrose aqueous solution (3.5g sucrose is added to 350ml with water), 1% maltose aqueous solution (3.5g maltose Add water to make the volume 350ml), soak for 30min, reflux for 30min, filter with gauze while it is hot, and obtain different sugar-astragalus extracts.
2.2黄芪甲苷,毛蕊异黄酮葡萄糖苷,芒柄花苷和毛蕊异黄酮含量测定2.2 Determination of astragaloside IV, acteosin glucoside, formononetin and acteosin
2.2.1仪器及试药2.2.1 Instruments and reagents
Agilent 1260型高效液相色谱仪,配有DAD检测器(美国安捷伦公司);Agilent1200型高效液相色谱仪,配有ELSD检测器(美国安捷伦公司);DZKW-4型电子恒温水浴锅(北京中兴伟业仪器有限公司);DK-98-IIA电热恒温水浴锅(天津市泰斯特仪器有限公司);ME204/02型电子天平[梅特勒–托利多仪器(上海)有限公司,十万分之一天平];KQ-250DE型数控超声波清洗器(昆山市超声仪器有限公司); HC-3018高速离心机(安徽中科中佳科学仪器有限公司);固相萃取小柱UniEIut C18 EC柱(1000mg/6ml)(华谱科仪北京科技有限公司)。Agilent 1260 high performance liquid chromatograph equipped with DAD detector (Agilent Corporation, USA); Agilent 1200 high performance liquid chromatography instrument equipped with ELSD detector (Agilent Corporation USA); DZKW-4 electronic constant temperature water bath (Beijing ZTE Weiye Instrument Co., Ltd.); DK-98-IIA electric heating constant temperature water bath (Tianjin Test Instrument Co., Ltd.); ME204/02 electronic balance [Mettler-Toledo Instrument (Shanghai) Co., Ltd., parts per 100,000 One day level]; KQ-250DE type numerical control ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); HC-3018 high-speed centrifuge (Anhui Zhongke Zhongjia Scientific Instrument Co., Ltd.); solid phase extraction column UniEIut C18 EC column (1000mg /6ml) (China Spectrum Instrument Beijing Technology Co., Ltd.).
对照品黄芪甲苷(批号CHB170727),毛蕊异黄酮葡萄糖苷(批号CHB161105),芒柄花苷(批号CHB150517),毛蕊异黄酮(批号 CHB161104)均购自成都克洛玛生物科技有限公司,纯度为HPlC≥ 98%;乙腈(色谱纯,赛默飞世尔科技有限公司),甲醇(色谱纯,赛默飞世尔科技有限公司),甲酸为分析纯,购于国药集团化学试剂有限公司。水为娃哈哈纯净水。The reference substance astragaloside (batch number CHB170727), calycosin glucoside (batch number CHB161105), formononetin (batch number CHB150517), and acteocoside (batch number CHB161104) were all purchased from Chengdu Croma Biotechnology Co., Ltd., with a purity of HPlC≥ 98%; acetonitrile (chromatographically pure, Thermo Fisher Scientific Co., Ltd.), methanol (chromatographically pure, Thermo Fisher Scientific Co., Ltd.), and formic acid were analytically pure, purchased from Sinopharm Chemical Reagent Co., Ltd. The water is Wahaha purified water.
2.2.2供试品溶液的制备2.2.2 Preparation of the test solution
皂苷类成分供试品溶液的制备:取不同糖-黄芪提取液5ml,加入 20ml60%甲醇,超声混合,加入10ml氨水,混匀,置于3600r/min离心10min,上清液过华谱UniEIut C18 EC柱(1000mg/6ml),用10ml 纯净水洗脱,再用5ml甲醇洗脱,收集甲醇洗脱液,8000r/min离心5min,取上清液,过0.45μm微孔滤膜,即得。The preparation of saponins component need testing solution: get different sugar-astragali extract 5ml, add 20ml60% methyl alcohol, ultrasonically mix, add 10ml ammoniacal liquor, mix well, be placed in 3600r/min centrifugal 10min, supernatant passes Chinese spectrum UniEIut C18 EC column (1000mg/6ml), elute with 10ml of pure water, then 5ml of methanol, collect the methanol eluate, centrifuge at 8000r/min for 5min, take the supernatant, pass through a 0.45μm microporous membrane to obtain the product.
黄酮类成分供试品溶液的制备:取不同糖-黄芪提取液300μl加水 700μl,置1.5ml离心管中,12000r/min离心5min,取上清,过0.45μm 微孔滤膜,即得。Preparation of the test solution of flavonoid components: Take 300 μl of different sugar-astragalus extracts, add 700 μl of water, put them in a 1.5ml centrifuge tube, centrifuge at 12000r/min for 5min, take the supernatant, and pass through a 0.45μm microporous membrane to obtain the product.
2.2.3对照品溶液的制备2.2.3 Preparation of reference solution
取黄芪甲苷,毛蕊异黄酮葡萄糖苷,芒柄花苷和毛蕊异黄酮对照品适量,精密称定,加甲醇制备1mg/ml的储备液。将储备液稀释成不同系列浓度,建立工作曲线。Take astragaloside IV, acteosin glucoside, formononetin and acteosin reference substance appropriate amount, accurately weighed, add methanol to prepare 1mg/ml stock solution. Dilute the stock solution into different serial concentrations to establish a working curve.
黄芪甲苷的线性方程为lnY=1.3271lnX+9.9314,r=1.0000;毛蕊异黄酮葡萄糖苷的线性方程为Y=35129X+14,r=0.9998;芒柄花苷的线性方程为Y=10024X+33,r=0.9998;毛蕊异黄酮的线性方程为 Y=4656X+25,r=0.9995。The linear equation of astragaloside IV is lnY=1.3271lnX+9.9314, r=1.0000; the linear equation of actecoside glucoside is Y=35129X+14, r=0.9998; the linear equation of formononetin is Y=10024X+33, r=0.9998; the linear equation of calycosin is Y=4656X+25, r=0.9995.
2.2.4含量测定方法2.2.4 Content determination method
皂苷类成分含量测定方法:采用Agilent 1200型液相色谱仪(配有 ELSD检测器)进行分析,色谱柱:Thermo Acclaim 120 C18 (250×4.6mm,5μm);流动相:0.1%甲酸水(A)~0.1%甲酸乙腈(B),梯度洗脱:0~5min,5%~10%B;5~10min,10%~32%B;10~30min, 32%~45%B;30~35min,45%~95%B;35~40min,95%~20%B),柱温:室温,流速1ml/min,漂移管温度100℃,载气流速2.5l/min,进样量 20μl。Determination method of saponins content: adopt Agilent 1200 type liquid chromatograph (equipped with ELSD detector) to analyze, chromatographic column: Thermo Acclaim 120 C18 (250 * 4.6mm, 5 μ m); Mobile phase: 0.1% formic acid water (A )~0.1% formic acid acetonitrile (B), gradient elution: 0~5min, 5%~10%B; 5~10min, 10%~32%B; 10~30min, 32%~45%B; 30~35min , 45%~95%B; 35~40min, 95%~20%B), column temperature: room temperature, flow rate 1ml/min, drift tube temperature 100°C, carrier gas flow rate 2.5l/min, injection volume 20μl.
黄酮类成分含量测定方法:采用Agilent 1260型高效液相色谱仪 (配有DAD检测器)进行分析,色谱柱:Thermo Acclaim 120 C18 (250×4.6mm,5μm);流动相:0.1%甲酸水溶液(A)与0.1%甲酸乙腈(B),梯度洗脱:0~8min,5%~20%B;8~15min,20%~25%B;15~20min, 25%B;20~30min,25%~40%B;30~40min,40%~60%B;流速1ml/min;检测波长260nm;柱温25℃;进样量10μl。Flavonoid content determination method: adopt Agilent 1260 type high performance liquid chromatograph (equipped with DAD detector) to analyze, chromatographic column: Thermo Acclaim 120 C18 (250 * 4.6mm, 5 μ m); Mobile phase: 0.1% formic acid aqueous solution ( A) with 0.1% formic acid acetonitrile (B), gradient elution: 0~8min, 5%~20%B; 8~15min, 20%~25%B; 15~20min, 25%B; 20~30min, 25% % ~ 40% B; 30 ~ 40min, 40% ~ 60% B; flow rate 1ml/min; detection wavelength 260nm; column temperature 25 ℃; injection volume 10μl.
2.3实验结果2.3 Experimental results
不同糖-黄芪提取液中有效成分含量测定结果如表2所示。Table 2 shows the content determination results of active ingredients in different sugar-astragalus extracts.
表2不同糖-黄芪提取液中有效成分含量测定结果Table 2 Determination results of active ingredients in different sugar-Astragalus extracts
*P<0.05VS水*P<0.05 VS water
从表2中可以看出,葡萄糖、蔗糖、麦芽糖(1g/100ml浓度) 均能够不同程度地提升黄芪中有效成分含量,其中以蔗糖的效果最为明显。It can be seen from Table 2 that glucose, sucrose, and maltose (1g/100ml concentration) can all increase the content of active ingredients in Radix Astragali to varying degrees, and the effect of sucrose is the most obvious.
实施例三不同糖溶液提取生黄芪饮片实验Example 3 Extraction of Raw Astragalus Pieces with Different Sugar Solutions
3.1不同糖-黄芪提取液的制备方法(不同1%糖提取两次)3.1 Preparation method of different sugar-Astragalus extract (extract twice with different 1% sugar)
同一批次生黄芪饮片(来源于山西陵川)取4份(HQ,HQ+1%蔗糖,HQ+1%麦芽糖,HQ+1%乳糖),每份50g。分别加入7倍量的水 (350ml水),1%蔗糖水溶液(3.5g蔗糖加水定容于350ml),1%麦芽糖水溶液(3.5g麦芽糖加水定容于350ml),1%乳糖水溶液(3.5g 乳糖加水定容于350ml)浸泡30min,回流30min,趁热用纱布过滤,药渣再分别加6倍量水(300ml水),1%蔗糖水溶液(3.0g蔗糖加水定容于300ml),1%麦芽糖水溶液(3.0g麦芽糖加水定容于300ml), 1%乳糖水溶液(3.0g乳糖加水定容于300ml),回流20min,趁热过滤,合并2次滤液,得到不同糖-黄芪提取液。The same batch of raw Astragalus decoction pieces (from Lingchuan, Shanxi) took 4 parts (HQ, HQ+1% sucrose, HQ+1% maltose, HQ+1% lactose), each 50g. Add 7 times the amount of water (350ml water), 1% sucrose aqueous solution (3.5g sucrose, add water to 350ml), 1% maltose aqueous solution (3.5g maltose, add water to 350ml), 1% lactose aqueous solution (3.5g lactose Add water to 350ml), soak for 30min, reflux for 30min, filter with gauze while hot, add 6 times the amount of water (300ml water), 1% sucrose aqueous solution (3.0g sucrose and water to 300ml), 1% maltose Aqueous solution (3.0g maltose, add water to 300ml), 1% lactose aqueous solution (3.0g lactose, add water to 300ml), reflux for 20min, filter while hot, combine 2 filtrates to obtain different sugars - astragalus extract.
3.2黄芪甲苷,毛蕊异黄酮葡萄糖苷,芒柄花苷和毛蕊异黄酮含量测定3.2 Determination of astragaloside IV, acteosin glucoside, formononetin and acteosin
3.2.1仪器及试药3.2.1 Instruments and reagents
Agilent 1260型高效液相色谱仪,配有DAD检测器(美国安捷伦公司);Agilent1200型高效液相色谱仪,配有ELSD检测器(美国安捷伦公司);DZKW-4型电子恒温水浴锅(北京中兴伟业仪器有限公司);DK-98-IIA电热恒温水浴锅(天津市泰斯特仪器有限公司);ME204/02型电子天平[梅特勒–托利多仪器(上海)有限公司,十万分之一天平];KQ-250DE型数控超声波清洗器(昆山市超声仪器有限公司); HC-3018高速离心机(安徽中科中佳科学仪器有限公司);固相萃取小柱UniEIutC18EC柱(1000mg/6ml)(华谱科仪北京科技有限公司)。Agilent 1260 high performance liquid chromatograph equipped with DAD detector (Agilent Corporation, USA); Agilent 1200 high performance liquid chromatography instrument equipped with ELSD detector (Agilent Corporation USA); DZKW-4 electronic constant temperature water bath (Beijing ZTE Weiye Instrument Co., Ltd.); DK-98-IIA electric heating constant temperature water bath (Tianjin Test Instrument Co., Ltd.); ME204/02 electronic balance [Mettler-Toledo Instrument (Shanghai) Co., Ltd., parts per 100,000 One day level]; KQ-250DE type numerical control ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); HC-3018 high-speed centrifuge (Anhui Zhongke Zhongjia Scientific Instrument Co., Ltd.); solid phase extraction column UniEIutC18EC column (1000mg/6ml ) (China Spectrum Instrument Beijing Technology Co., Ltd.).
对照品黄芪甲苷(批号CHB170727),毛蕊异黄酮葡萄糖苷(批号CHB161105),芒柄花苷(批号CHB150517),毛蕊异黄酮(批号 CHB161104)均购自成都克洛玛生物科技有限公司,纯度为HPlC≥ 98%;乙腈(色谱纯,赛默飞世尔科技有限公司),甲醇(色谱纯,赛默飞世尔科技有限公司),甲酸为分析纯,购于国药集团化学试剂有限公司。水为娃哈哈纯净水。The reference substance astragaloside (batch number CHB170727), calycosin glucoside (batch number CHB161105), formononetin (batch number CHB150517), and acteocoside (batch number CHB161104) were all purchased from Chengdu Croma Biotechnology Co., Ltd., with a purity of HPlC≥ 98%; acetonitrile (chromatographically pure, Thermo Fisher Scientific Co., Ltd.), methanol (chromatographically pure, Thermo Fisher Scientific Co., Ltd.), and formic acid were analytically pure, purchased from Sinopharm Chemical Reagent Co., Ltd. The water is Wahaha purified water.
3.2.2供试品溶液的制备3.2.2 Preparation of the test solution
皂苷类成分供试品溶液的制备:取不同糖-黄芪提取液5ml,加入 20ml 60%甲醇,超声混合,加入10ml氨水,混匀,置于3600r/min离心10min,上清液过华谱UniEIut C18 EC柱(1000mg/6ml),用10ml 纯净水洗脱,再用5ml甲醇洗脱,收集甲醇洗脱液,8000r/min离心5min,取上清液,过0.45μm微孔滤膜,即得。The preparation of saponins component need testing solution: get different sugar-astragali extract 5ml, add 20ml 60% methyl alcohol, ultrasonically mix, add 10ml ammoniacal liquor, mix well, be placed in 3600r/min centrifugal 10min, supernatant is crossed Chinese spectrum UniEIut C18 EC column (1000mg/6ml), elute with 10ml of pure water, then 5ml of methanol, collect the methanol eluate, centrifuge at 8000r/min for 5min, take the supernatant, and pass through a 0.45μm microporous membrane to obtain .
黄酮类成分供试品溶液的制备:取不同糖-黄芪提取液300μl加水 700μl,置1.5ml离心管中,12000r/min离心5min,取上清,过0.45μm 微孔滤膜,即得。Preparation of the test solution of flavonoid components: Take 300 μl of different sugar-astragalus extracts, add 700 μl of water, put them in a 1.5ml centrifuge tube, centrifuge at 12000r/min for 5min, take the supernatant, and pass through a 0.45μm microporous membrane to obtain the product.
3.2.3对照品溶液的制备3.2.3 Preparation of reference solution
取黄芪甲苷,毛蕊异黄酮葡萄糖苷,芒柄花苷和毛蕊异黄酮对照品适量,精密称定,加甲醇制备1mg/ml的储备液。将储备液稀释成不同系列浓度,建立工作曲线。Take astragaloside IV, acteosin glucoside, formononetin and acteosin reference substance appropriate amount, accurately weighed, add methanol to prepare 1mg/ml stock solution. Dilute the stock solution into different serial concentrations to establish a working curve.
黄芪甲苷的线性方程为lnY=1.3271lnX+9.9314,r=1.0000;毛蕊异黄酮葡萄糖苷的线性方程为Y=35129X+14,r=0.9998;芒柄花苷的线性方程为Y=10024X+33,r=0.9998;毛蕊异黄酮的线性方程为 Y=4656X+25,r=0.9995。The linear equation of astragaloside IV is lnY=1.3271lnX+9.9314, r=1.0000; the linear equation of actecoside glucoside is Y=35129X+14, r=0.9998; the linear equation of formononetin is Y=10024X+33, r=0.9998; the linear equation of calycosin is Y=4656X+25, r=0.9995.
3.2.4含量测定方法3.2.4 Content determination method
皂苷类成分含量测定方法:采用Agilent 1200型液相色谱仪(配有ELSD检测器)进行分析,色谱柱:Thermo Acclaim 120 C18 (250×4.6mm,5μm);流动相:0.1%甲酸水(A)~0.1%甲酸乙腈(B),梯度洗脱:0~5min,5%~10%B;5~10min,10%~32%B;10~30min,32%~45%B;30~35min,45%~95%B;35~40min,95%~20%B),柱温:室温,流速1ml/min,漂移管温度100℃,载气流速2.5l/min,进样量 20μl。Determination method of saponins content: adopt Agilent 1200 type liquid chromatograph (equipped with ELSD detector) to analyze, chromatographic column: Thermo Acclaim 120 C18 (250 * 4.6mm, 5 μ m); Mobile phase: 0.1% formic acid water (A )~0.1% formic acid acetonitrile (B), gradient elution: 0~5min, 5%~10%B; 5~10min, 10%~32%B; 10~30min, 32%~45%B; 30~35min , 45%~95%B; 35~40min, 95%~20%B), column temperature: room temperature, flow rate 1ml/min, drift tube temperature 100°C, carrier gas flow rate 2.5l/min, injection volume 20μl.
黄酮类成分含量测定方法:采用Agilent 1260型高效液相色谱仪 (配有DAD检测器)进行分析,色谱柱:Thermo Acclaim 120 C18 (250×4.6mm,5μm);流动相:0.1%甲酸水溶液(A)与0.1%甲酸乙腈(B),梯度洗脱:0~8min,5%~20%B;8~15min,20%~25%B;15~20min, 25%B;20~30min,25%~40%B;30~40min,40%~60%B;流速1ml/min;检测波长260nm;柱温25℃;进样量10μl。Flavonoid content determination method: adopt Agilent 1260 type high performance liquid chromatograph (equipped with DAD detector) to analyze, chromatographic column: Thermo Acclaim 120 C18 (250 * 4.6mm, 5 μ m); Mobile phase: 0.1% formic acid aqueous solution ( A) with 0.1% formic acid acetonitrile (B), gradient elution: 0~8min, 5%~20%B; 8~15min, 20%~25%B; 15~20min, 25%B; 20~30min, 25% % ~ 40% B; 30 ~ 40min, 40% ~ 60% B; flow rate 1ml/min; detection wavelength 260nm; column temperature 25 ℃; injection volume 10μl.
3.3实验结果3.3 Experimental results
不同糖-黄芪提取液中有效成分含量测定结果如表3所示。Table 3 shows the content determination results of active ingredients in different sugar-astragalus extracts.
表3不同糖-黄芪提取液中有效成分含量测定结果Table 3 Determination results of active ingredients in different sugar-Astragalus extract
*P<0.05VS水*P<0.05 VS water
从表3中可以看出,蔗糖、麦芽糖、乳糖(1g/100ml浓度)均能够不同程度地提升黄芪中有效成分含量,其中以蔗糖效果最为明显。It can be seen from Table 3 that sucrose, maltose, and lactose (1g/100ml concentration) can all increase the content of active ingredients in Astragalus membranaceus to varying degrees, and sucrose has the most obvious effect.
综合表1和表3结果可知,蔗糖能显著提升黄芪中主要活性成分,包括黄酮类(毛蕊异黄酮葡萄糖苷、芒柄花苷、毛蕊异黄酮)和皂苷类成分(黄芪甲苷)的提取率。Based on the results in Table 1 and Table 3, it can be seen that sucrose can significantly increase the extraction rate of the main active components in Astragalus membranaceus, including flavonoids (actecoisoflavone glucoside, formononetin, and actecoside) and saponins (astragaloside IV).
实施例四不同浓度蔗糖溶液提取生黄芪饮片Example 4 Extraction of Raw Astragalus Pieces with Sucrose Solutions of Different Concentrations
4.1不同浓度蔗糖-黄芪提取液的制备(0-10%不同浓度蔗糖提取)4.1 Preparation of different concentrations of sucrose-Astragalus extract (0-10% different concentrations of sucrose extraction)
同一批次生黄芪饮片(来源于山西陵川)取6份(HQ,HQ+0.25%蔗糖,HQ+0.5%蔗糖,HQ+1%蔗糖,HQ+2%蔗糖,HQ+10%蔗糖),每份50g。分别加入7倍量的水(350ml水),0.25%蔗糖水溶液(0.9g 蔗糖加水定容于350ml),0.5%蔗糖水溶液(1.8g蔗糖加水定容于350ml),1%蔗糖水溶液(3.5g蔗糖加水定容于350ml),1.25%蔗糖水溶液(4.4g蔗糖加水定容于350ml),1.5%蔗糖水溶液(5.3g蔗糖加水定容于350ml),2%蔗糖水溶液(7g蔗糖加水定容于350ml), 10%蔗糖水溶液(35g蔗糖加水定容于350ml),浸泡30min,回流30min,趁热用纱布过滤,药渣再分别加6倍量水(300ml水),0.25%蔗糖水溶液(0.8g蔗糖加水定容于300ml),0.5%蔗糖水溶液(1.5g蔗糖加水定容于300ml),1%蔗糖水溶液(3.0g蔗糖加水定容于300ml), 1.25%蔗糖水溶液(3.8g蔗糖加水定容于300ml),1.5%蔗糖水溶液(4.5g 蔗糖加水定容于300ml),2%蔗糖水溶液(6.0g蔗糖加水定容于300ml), 10%蔗糖水溶液(30g蔗糖加水定容于300ml),回流20min,趁热过滤,合并2次滤液,得到不同浓度蔗糖黄芪提取液。The same batch of raw Astragalus decoction pieces (from Lingchuan, Shanxi) took 6 parts (HQ, HQ+0.25% sucrose, HQ+0.5% sucrose, HQ+1% sucrose, HQ+2% sucrose, HQ+10% sucrose), 50g per serving. Add 7 times the amount of water (350ml water), 0.25% sucrose aqueous solution (0.9g sucrose, add water to 350ml), 0.5% sucrose aqueous solution (1.8g sucrose, add water to 350ml), 1% sucrose aqueous solution (3.5g sucrose Add water to 350ml), 1.25% sucrose aqueous solution (4.4g sucrose, add water to 350ml), 1.5% sucrose aqueous solution (5.3g sucrose to 350ml), 2% sucrose aqueous solution (7g sucrose to 350ml) , 10% sucrose aqueous solution (35g sucrose, add water to make up to 350ml), soak for 30min, reflux for 30min, filter with gauze while hot, then add 6 times the amount of water (300ml water), 0.25% sucrose aqueous solution (0.8g sucrose add water 0.5% sucrose aqueous solution (1.5g sucrose, add water to 300ml), 1% sucrose aqueous solution (3.0g sucrose, add water to 300ml), 1.25% sucrose aqueous solution (3.8g sucrose, add water to 300ml) , 1.5% sucrose aqueous solution (4.5g sucrose, add water to 300ml), 2% sucrose aqueous solution (6.0g sucrose, add water to 300ml), 10% sucrose aqueous solution (30g sucrose, add water to 300ml), reflux for 20min, while hot Filtrate and combine the two filtrates to obtain extracts of Astragalus membranaceus with different concentrations of sucrose.
4.2黄芪甲苷,毛蕊异黄酮葡萄糖苷,芒柄花苷和毛蕊异黄酮含量测定4.2 Determination of astragaloside IV, acteosin glucoside, formononetin and acteosin
4.2.1仪器及试药4.2.1 Instruments and reagents
Agilent 1260型高效液相色谱仪,配有DAD检测器(美国安捷伦公司);Agilent1200型高效液相色谱仪,配有ELSD检测器(美国安捷伦公司);DZKW-4型电子恒温水浴锅(北京中兴伟业仪器有限公司);DK-98-IIA电热恒温水浴锅(天津市泰斯特仪器有限公司);ME204/02型电子天平[梅特勒–托利多仪器(上海)有限公司,十万分之一天平];KQ-250DE型数控超声波清洗器(昆山市超声仪器有限公司); HC-3018高速离心机(安徽中科中佳科学仪器有限公司);固相萃取小柱UniEIutC18EC柱(1000mg/6ml)(华谱科仪北京科技有限公司)。Agilent 1260 high performance liquid chromatograph equipped with DAD detector (Agilent Corporation, USA); Agilent 1200 high performance liquid chromatography instrument equipped with ELSD detector (Agilent Corporation USA); DZKW-4 electronic constant temperature water bath (Beijing ZTE Weiye Instrument Co., Ltd.); DK-98-IIA electric heating constant temperature water bath (Tianjin Test Instrument Co., Ltd.); ME204/02 electronic balance [Mettler-Toledo Instrument (Shanghai) Co., Ltd., parts per 100,000 One day level]; KQ-250DE type numerical control ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); HC-3018 high-speed centrifuge (Anhui Zhongke Zhongjia Scientific Instrument Co., Ltd.); solid phase extraction column UniEIutC18EC column (1000mg/6ml ) (China Spectrum Instrument Beijing Technology Co., Ltd.).
对照品黄芪甲苷(批号CHB170727),毛蕊异黄酮葡萄糖苷(批号CHB161105),芒柄花苷(批号CHB150517),毛蕊异黄酮(批号 CHB161104)均购自成都克洛玛生物科技有限公司,纯度为HPlC≥ 98%;乙腈(色谱纯,赛默飞世尔科技有限公司),甲醇(色谱纯,赛默飞世尔科技有限公司),甲酸为分析纯,购于国药集团化学试剂有限公司。水为娃哈哈纯净水。The reference substance astragaloside (batch number CHB170727), calycosin glucoside (batch number CHB161105), formononetin (batch number CHB150517), and acteocoside (batch number CHB161104) were all purchased from Chengdu Croma Biotechnology Co., Ltd., with a purity of HPlC≥ 98%; acetonitrile (chromatographically pure, Thermo Fisher Scientific Co., Ltd.), methanol (chromatographically pure, Thermo Fisher Scientific Co., Ltd.), and formic acid were analytically pure, purchased from Sinopharm Chemical Reagent Co., Ltd. The water is Wahaha purified water.
4.2.2供试品溶液的制备4.2.2 Preparation of the test solution
皂苷类成分供试品溶液的制备:取不同糖-黄芪提取液5ml,加入 20ml60%甲醇,超声混合,加入10ml氨水,混匀,置于3600r/min离心10min,上清液过华谱UniEIutC18EC柱(1000mg/6ml),用10ml 纯净水洗脱,再用5ml甲醇洗脱,收集甲醇洗脱液,8000r/min离心5min,取上清液,过0.45μm微孔滤膜,即得。The preparation of saponins component need testing solution: get different sugar-astragali extract 5ml, add 20ml60% methyl alcohol, ultrasonically mix, add 10ml ammoniacal liquor, mix evenly, be placed in 3600r/min centrifugation 10min, supernatant is crossed Chinese spectrum UniEIutC18EC column (1000mg/6ml), eluted with 10ml of pure water, then 5ml of methanol, collected the methanol eluate, centrifuged at 8000r/min for 5min, took the supernatant, passed through a 0.45μm microporous membrane, and obtained.
黄酮类成分供试品溶液的制备:取不同糖-黄芪提取液300μl加水 700μl,置1.5ml离心管中,12000r/min离心5min,取上清,过0.45μm 微孔滤膜,即得。Preparation of the test solution of flavonoid components: Take 300 μl of different sugar-astragalus extracts, add 700 μl of water, put them in a 1.5ml centrifuge tube, centrifuge at 12000r/min for 5min, take the supernatant, and pass through a 0.45μm microporous membrane to obtain the product.
4.2.3对照品溶液的制备4.2.3 Preparation of reference solution
取黄芪甲苷,毛蕊异黄酮葡萄糖苷,芒柄花苷和毛蕊异黄酮对照品适量,精密称定,加甲醇制备1mg/ml的储备液。将储备液稀释成不同系列浓度,建立工作曲线。Take astragaloside IV, acteosin glucoside, formononetin and acteosin reference substance appropriate amount, accurately weighed, add methanol to prepare 1mg/ml stock solution. Dilute the stock solution into different serial concentrations to establish a working curve.
黄芪甲苷的线性方程为lnY=1.3271lnX+9.9314,r=1.0000;毛蕊异黄酮葡萄糖苷的线性方程为Y=35129X+14,r=0.9998;芒柄花苷的线性方程为Y=10024X+33,r=0.9998;毛蕊异黄酮的线性方程为 Y=4656X+25,r=0.9995。The linear equation of astragaloside IV is lnY=1.3271lnX+9.9314, r=1.0000; the linear equation of actecoside glucoside is Y=35129X+14, r=0.9998; the linear equation of formononetin is Y=10024X+33, r=0.9998; the linear equation of calycosin is Y=4656X+25, r=0.9995.
4.2.4含量测定方法4.2.4 Content determination method
皂苷类成分含量测定方法:采用Agilent 1200型液相色谱仪(配有 ELSD检测器)进行分析,色谱柱:Thermo Acclaim 120 C18 (250×4.6mm,5μm);流动相:0.1%甲酸水(A)~0.1%甲酸乙腈(B),梯度洗脱:0~5min,5%~10%B;5~10min,10%~32%B;10~30min,32%~45%B;30~35min,45%~95%B;35~40min,95%~20%B),柱温:室温,流速1ml/min,漂移管温度100℃,载气流速2.5l/min,进样量 20μl。Determination method of saponins content: adopt Agilent 1200 type liquid chromatograph (equipped with ELSD detector) to analyze, chromatographic column: Thermo Acclaim 120 C18 (250 * 4.6mm, 5 μ m); Mobile phase: 0.1% formic acid water (A )~0.1% formic acid acetonitrile (B), gradient elution: 0~5min, 5%~10%B; 5~10min, 10%~32%B; 10~30min, 32%~45%B; 30~35min , 45%~95%B; 35~40min, 95%~20%B), column temperature: room temperature, flow rate 1ml/min, drift tube temperature 100°C, carrier gas flow rate 2.5l/min, injection volume 20μl.
黄酮类成分含量测定方法:采用Agilent 1260型高效液相色谱仪 (配有DAD检测器)进行分析,色谱柱:Thermo Acclaim 120 C18 (250×4.6mm,5μm);流动相:0.1%甲酸水溶液(A)与0.1%甲酸乙腈(B),梯度洗脱:0~8min,5%~20%B;8~15min,20%~25%B;15~20min, 25%B;20~30min,25%~40%B;30~40min,40%~60%B;流速1ml/min;检测波长260nm;柱温25℃;进样量10μl。Flavonoid content determination method: adopt Agilent 1260 type high performance liquid chromatograph (equipped with DAD detector) to analyze, chromatographic column: Thermo Acclaim 120 C18 (250 * 4.6mm, 5 μ m); Mobile phase: 0.1% formic acid aqueous solution ( A) with 0.1% formic acid acetonitrile (B), gradient elution: 0~8min, 5%~20%B; 8~15min, 20%~25%B; 15~20min, 25%B; 20~30min, 25% % ~ 40% B; 30 ~ 40min, 40% ~ 60% B; flow rate 1ml/min; detection wavelength 260nm; column temperature 25 ℃; injection volume 10μl.
4.3实验结果4.3 Experimental results
不同浓度蔗糖溶液提取生黄芪饮片所获得的黄芪提取液中有效成分含量测定结果如表4所示。Table 4 shows the content determination results of active ingredients in the Astragalus extract obtained by extracting raw Astragalus decoction pieces with different concentrations of sucrose solutions.
表4不同浓度蔗糖所获得的黄芪提取液中有效成分含量测定结果Table 4 Determination of active ingredient content in the astragalus extract obtained by different concentrations of sucrose
*P<0.05VS水*P<0.05 VS water
从表4中可以看出,蔗糖浓度在0.25g/100ml至1.25g/100ml 浓度范围内均能够不同程度地提升黄芪中有效成分含量,其中以蔗糖浓度在1g/100ml至1.25g/100ml浓度范围内效果最为明显。此外,蔗糖浓度在10g/100ml浓度时也能够提升黄芪中有效成分含量。It can be seen from Table 4 that the concentration of sucrose in the range of 0.25g/100ml to 1.25g/100ml can increase the content of active ingredients in Radix Astragali to varying degrees, among which the concentration of sucrose in the range of 1g/100ml to 1.25g/100ml The inner effect is most obvious. In addition, when the concentration of sucrose is 10g/100ml, it can also increase the content of active ingredients in Astragalus membranaceus.
以上所述的仅是本发明的实施例,方案中公知的具体结构及特性等常识在此未作过多描述。应当指出,对于本领域的技术人员来说,在不脱离本发明的前提下,还可以作出若干变形和改进,这些也应该视为本发明的保护范围,这些都不会影响本发明实施的效果和专利的实用性。本发明要求的保护范围应当以其权利要求的内容为准,说明书中的具体实施方式等记载可以用于解释权利要求的内容。What is described above is only an embodiment of the present invention, and common knowledge such as specific structures and characteristics known in the scheme are not described here too much. It should be pointed out that for those skilled in the art, without departing from the premise of the present invention, some modifications and improvements can also be made, which should also be regarded as the protection scope of the present invention, and these will not affect the effect of the implementation of the present invention and the availability of patents. The scope of protection required by the present invention shall be based on the content of the claims, and the specific implementation methods and other records in the specification may be used to interpret the content of the claims.
以上对本发明实施例进行了详细介绍,本文中应用了具体个例对本发明的原理及实施方式进行了阐述,以上实施例的说明仅用于帮助理解本发明的方法及其核心思想。同时,本领域技术人员依据本发明的思想,基于本发明的具体实施方式及应用范围上做出的改变或变形之处,都属于本发明保护的范围。综上所述,本说明书内容不应理解为对本发明的限制。The embodiments of the present invention have been described in detail above, and specific examples are used in this paper to illustrate the principle and implementation of the present invention. The descriptions of the above embodiments are only used to help understand the method and core idea of the present invention. At the same time, any changes or deformations made by those skilled in the art based on the idea of the present invention, based on the specific implementation methods and application scope of the present invention, all belong to the scope of protection of the present invention. In summary, the contents of this specification should not be construed as limiting the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110886217.7A CN116199732B (en) | 2021-08-03 | 2021-08-03 | A method for increasing the extraction of active ingredients from Astragalus membranaceus using sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110886217.7A CN116199732B (en) | 2021-08-03 | 2021-08-03 | A method for increasing the extraction of active ingredients from Astragalus membranaceus using sugar |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116199732A true CN116199732A (en) | 2023-06-02 |
| CN116199732B CN116199732B (en) | 2025-12-12 |
Family
ID=86515990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110886217.7A Active CN116199732B (en) | 2021-08-03 | 2021-08-03 | A method for increasing the extraction of active ingredients from Astragalus membranaceus using sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116199732B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117205251A (en) * | 2023-10-16 | 2023-12-12 | 西藏天虹科技股份有限责任公司 | Preparation method of Polygonum multiflorum superfine powder |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10279495A (en) * | 1997-04-03 | 1998-10-20 | Japan Torukusu:Kk | Production of saponin essence liquid extracted with fructose, saponin essence liquid extracted with fructose, production of crystalline saponin mannitol additive and fructose-containing crystalline saponin mannitol additive powder |
| KR20030028905A (en) * | 2001-10-04 | 2003-04-11 | 원광제약 (주) | New method for preparing woohwangchungshimwon suspension using dipping method in sugar |
| KR100982434B1 (en) * | 2010-03-31 | 2010-09-15 | 주식회사 경희매니지먼트컴퍼니 | Method for extracting natural substance using sucrose aqueous solution, composition including the same and functional food employing the same |
| US20130149322A1 (en) * | 2010-06-07 | 2013-06-13 | Universiteit Leiden | Process for extracting materials from biological material |
| CN105030845A (en) * | 2015-07-31 | 2015-11-11 | 中国中医科学院中药研究所 | Method for processing traditional Chinese medicines with honey |
| CN107737154A (en) * | 2017-12-04 | 2018-02-27 | 方建兵 | A kind of concocting method of Radix Astragali medicine materical crude slice |
| CN109464494A (en) * | 2018-12-22 | 2019-03-15 | 北京能济中药饮片有限公司 | A kind of processing method of preparing astragalus membranaceus |
| CN109717439A (en) * | 2019-01-30 | 2019-05-07 | 宁夏碧蜂源蜂产业有限公司 | A kind of preparation method of the health-care honey that suitable teenager drinks slurry |
| US20190247323A1 (en) * | 2016-10-10 | 2019-08-15 | Cj Cheiljedang Corporation | Extract from plant steeped in allulose and preparation method therefor |
-
2021
- 2021-08-03 CN CN202110886217.7A patent/CN116199732B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10279495A (en) * | 1997-04-03 | 1998-10-20 | Japan Torukusu:Kk | Production of saponin essence liquid extracted with fructose, saponin essence liquid extracted with fructose, production of crystalline saponin mannitol additive and fructose-containing crystalline saponin mannitol additive powder |
| KR20030028905A (en) * | 2001-10-04 | 2003-04-11 | 원광제약 (주) | New method for preparing woohwangchungshimwon suspension using dipping method in sugar |
| KR100982434B1 (en) * | 2010-03-31 | 2010-09-15 | 주식회사 경희매니지먼트컴퍼니 | Method for extracting natural substance using sucrose aqueous solution, composition including the same and functional food employing the same |
| US20130149322A1 (en) * | 2010-06-07 | 2013-06-13 | Universiteit Leiden | Process for extracting materials from biological material |
| CN105030845A (en) * | 2015-07-31 | 2015-11-11 | 中国中医科学院中药研究所 | Method for processing traditional Chinese medicines with honey |
| US20190247323A1 (en) * | 2016-10-10 | 2019-08-15 | Cj Cheiljedang Corporation | Extract from plant steeped in allulose and preparation method therefor |
| CN107737154A (en) * | 2017-12-04 | 2018-02-27 | 方建兵 | A kind of concocting method of Radix Astragali medicine materical crude slice |
| CN109464494A (en) * | 2018-12-22 | 2019-03-15 | 北京能济中药饮片有限公司 | A kind of processing method of preparing astragalus membranaceus |
| CN109717439A (en) * | 2019-01-30 | 2019-05-07 | 宁夏碧蜂源蜂产业有限公司 | A kind of preparation method of the health-care honey that suitable teenager drinks slurry |
Non-Patent Citations (1)
| Title |
|---|
| 蔡金坊等: "系统评价蜜炙对黄芪药效物质基础的改变", 中国实验方剂学杂志, vol. 22, no. 08, 30 April 2016 (2016-04-30), pages 47 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117205251A (en) * | 2023-10-16 | 2023-12-12 | 西藏天虹科技股份有限责任公司 | Preparation method of Polygonum multiflorum superfine powder |
| CN117205251B (en) * | 2023-10-16 | 2025-05-23 | 西藏天虹科技股份有限责任公司 | Preparation method of Polygonum multiflorum superfine powder |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116199732B (en) | 2025-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102641326B (en) | Astragalus extract, as well as preparation and application methods thereof | |
| CN106727806B (en) | A kind of preparation method of sanchi leaf total saposins | |
| CN105132172B (en) | A kind of method for preparing orris root flavonoids for tobacco from orris root | |
| JP7711346B2 (en) | Method for increasing exudation of sugar and glycoside components and use thereof | |
| CN102196814A (en) | Method for preparing extract fraction reinforced with ginsenosides Rg1 or Rb1 from ginseng | |
| CN108186474B (en) | Total flavone extract of Loranthus parasiticus of Loranthus, preparation method and application | |
| CN103224491A (en) | Method for extracting high-purity puerarin by using water as solvent | |
| CN107854522B (en) | Composition and preparation method and application thereof | |
| CN116199732A (en) | Method for increasing leaching of effective components of astragalus membranaceus by utilizing sugar | |
| CN101318955B (en) | Method for preparing effective component of kudzu root | |
| CN108653355A (en) | A kind of Herba Centipedae extract preparation method with anti-inflammatory effect | |
| CN104817601B (en) | Three flavones ingredient mixtures, preparation and its method are extracted from Herba lysimachiae capillipedis | |
| CN106589045B (en) | The preparation method of buckeye otoginsenoside | |
| CN103372034A (en) | Preparation method of ginkgo biloba extract | |
| CN109481531B (en) | Qi-benefiting and blood-nourishing composition as well as preparation method and application thereof | |
| CN116251134B (en) | A kind of Momordica grosvenori root hypoglycemic composition, application and preparation method | |
| CN101791340B (en) | Method for purifying active ingredients of compound Naodesheng | |
| CN107468761B (en) | A kind of preparation method and application of total triterpenoid acid extract of Ligustrum lucidum | |
| CN104725449A (en) | Paeoniflorin extracting method | |
| CN104435658B (en) | A kind of medicine for ischemia apoplexy prevention and treatment and preparation method thereof | |
| CN116271945B (en) | A method for increasing the extraction of effective components of licorice by using sugar | |
| CN116688558B (en) | A method for increasing the extraction of saponin components by using a low-concentration aqueous solution of a carbohydrate compound and its application | |
| CN115518136A (en) | A kind of preparation method of Dan'e Fukang preparation | |
| CN108186773B (en) | Weight-losing and lipid-lowering medicinal preparation and preparation method thereof | |
| CN1440979A (en) | Steroid saponin from sealwort as Chinese medicine material and its medicinal use and prepn process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |